A detailed history of Handelsbanken Fonder Ab transactions in Legend Biotech Corp stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 50,500 shares of LEGN stock, worth $2.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,500
Previous 46,900 7.68%
Holding current value
$2.02 Million
Previous $2.08 Million 18.49%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$43.55 - $59.88 $156,780 - $215,568
3,600 Added 7.68%
50,500 $2.46 Million
Q2 2024

Aug 05, 2024

BUY
$39.5 - $57.22 $284,400 - $411,984
7,200 Added 18.14%
46,900 $2.08 Million
Q4 2023

Feb 01, 2024

BUY
$57.25 - $69.74 $440,825 - $536,998
7,700 Added 24.06%
39,700 $2.39 Million
Q3 2023

Oct 19, 2023

BUY
$63.16 - $76.5 $296,852 - $359,550
4,700 Added 17.22%
32,000 $2.15 Million
Q2 2023

Aug 02, 2023

BUY
$46.28 - $75.01 $60,164 - $97,513
1,300 Added 5.0%
27,300 $1.89 Million
Q1 2023

Apr 28, 2023

BUY
$43.42 - $57.37 $212,758 - $281,113
4,900 Added 23.22%
26,000 $1.25 Million
Q4 2022

Feb 07, 2023

BUY
$38.8 - $55.46 $818,679 - $1.17 Million
21,100 New
21,100 $1.05 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.